FLURITAB-100
FLURBIPROFEN · by NOVAMED
Composition
SR Cap 200 mg: Flurbiprofen 200 mg; sustained-release capsules. Tab 50 mg/100 mg: Flurbiprofen 50 mg/100 mg.
Indications & Dosage
Pain and inflammation in rheumatic disease and other musculoskeletal disorders, Migraine, Postoperative analgesia, Mild to moderate pain: Adult & Children above 12 yrs: 150-200 mg daily in 2-4 divided doses, then increased to 300 mg daily, dose to be increased only in acute conditions. Dysmenorrhoea: Adult & Children above 12 yrs: Initially 100 mg, then 50-100 mg every4-6 hours; max. 300 mg per day.
Contraindications
Active or recurrent GI bleeding or ulceration, cerebrovascular disease, history of GI bleeding or GI perforation related to previous NSAID therapy, history of recurrent GI haemorrhage, ischaemic heart disease, heart failure, peripheral arterial disease, moderate to severe renal impairment, aspirin/anti-inflammatory in-duced allergy.
Precautions
Renal, hepatic or cardiac impairment. GI disease, allergic disorders, avoid in acute porphyrias, coagulation defects, connective-tissue disorders, Crohns disease (may be exacerbated), elderly, oedema, risk factors for cardiovascular events, ulcerative colitis (may be exacerbated)
Interactions
Furosemide, anticoagulants.
Pregnancy
Contraindicated in pregnancy.
Lactation
Contraindicated or not recommended.
Side Effects
Angioedema, blood disorders, bronchospasm, colitis, Crohns disease, depression, diarrhoea, dizziness, drowsiness, fluid retention, GI bleeding and ulceration, GI disturbances, haematuria, headache, hearing disturbances, hypersensitivity reactions, insomnia, nausea, nervousness, photosensitivity, raised blood pressure, rashes, renal failure (especially in patients with preexisting renal impairment),tinnitus, vertigo. Rare: hepatic damage, interstitial fibrosis associated with NSAIDs, Stevens-Johnson syndrome, toxic epidermal necrolysis, visual disturbances, local irritation with use of rectal suppositories